Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy - PubMed (original) (raw)
Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy
Huey-Wen Hsiao et al. Immunity. 2009.
Free article
Abstract
The molecular process underlying T cell anergy is incompletely understood. Deltex1 (DTX1) is a Notch target with unknown physiological function. Here we show that Dtx1 was a transcription target of nuclear factor of activated T cells (NFAT) and participated in T cell anergy. DTX1 protein was upregulated during T cell anergy, and transgenic expression of Dtx1 attenuated T cell activation. DTX1 inhibited T cell activation by both E3-dependent and E3-independent mechanisms. In addition, DTX1 suppressed T cell activation in the absence of its Notch-binding domain. Importantly, DTX1 regulated the expression of two anergy-associated molecules, growth arrest and DNA-damage-inducible 45 beta (Gadd45 beta) and Cbl-b. DTX1 interacted with early growth response 2 (Egr-2) for optimum expression of Cbl-b. Furthermore, deficiency of DTX1 augmented T cell activation, conferred resistance to anergy induction, enhanced autoantibody generation, and increased inflammation. DTX1 therefore represents a component downstream of calcium-NFAT signaling that regulates T cell anergy.
Similar articles
- Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.
Hsu TS, Hsiao HW, Wu PJ, Liu WH, Lai MZ. Hsu TS, et al. J Immunol. 2014 Aug 15;193(4):1672-80. doi: 10.4049/jimmunol.1301416. Epub 2014 Jul 7. J Immunol. 2014. PMID: 25000980 - Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
Schmitz ML. Schmitz ML. Sci Signal. 2009 Jun 23;2(76):pe38. doi: 10.1126/scisignal.276pe38. Sci Signal. 2009. PMID: 19549983 Review. - Egr-2 and Egr-3 are negative regulators of T cell activation.
Safford M, Collins S, Lutz MA, Allen A, Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, Powell JD. Safford M, et al. Nat Immunol. 2005 May;6(5):472-80. doi: 10.1038/ni1193. Epub 2005 Apr 17. Nat Immunol. 2005. PMID: 15834410 - Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S, Penninger JM. Loeser S, et al. Semin Immunol. 2007 Jun;19(3):206-14. doi: 10.1016/j.smim.2007.02.004. Epub 2007 Mar 27. Semin Immunol. 2007. PMID: 17391982 Review. - Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF, Flening E, Yabas M, Teh C, Altin JA, Randall K, Thien CB, Langdon WY, Goodnow CC. Hoyne GF, et al. J Immunol. 2011 Feb 15;186(4):2024-32. doi: 10.4049/jimmunol.1002296. Epub 2011 Jan 19. J Immunol. 2011. PMID: 21248249
Cited by
- Overview of Hepatitis B Vaccine Non-Response and Associated B Cell Amnesia: A Scoping Review.
Bello N, Hudu SA, Alshrari AS, Imam MU, Jimoh AO. Bello N, et al. Pathogens. 2024 Jul 2;13(7):554. doi: 10.3390/pathogens13070554. Pathogens. 2024. PMID: 39057781 Free PMC article. Review. - Single-cell RNA sequencing reveals Immune Education promotes T cell survival in mice subjected to the cecal ligation and puncture sepsis model.
Ham SD, Abraham MN, Deutschman CS, Taylor MD. Ham SD, et al. Front Immunol. 2024 Mar 18;15:1366955. doi: 10.3389/fimmu.2024.1366955. eCollection 2024. Front Immunol. 2024. PMID: 38562928 Free PMC article. - Identification of Messenger RNA Signatures in Age-Dependent Renal Impairment.
Yanai K, Kaneko S, Aomatsu A, Hirai K, Ookawara S, Morishita Y. Yanai K, et al. Diagnostics (Basel). 2023 Dec 13;13(24):3653. doi: 10.3390/diagnostics13243653. Diagnostics (Basel). 2023. PMID: 38132237 Free PMC article. - The DTX Protein Family: An Emerging Set of E3 Ubiquitin Ligases in Cancer.
Scalia P, Williams SJ, Suma A, Carnevale V. Scalia P, et al. Cells. 2023 Jun 21;12(13):1680. doi: 10.3390/cells12131680. Cells. 2023. PMID: 37443713 Free PMC article. Review. - Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.
Laletin V, Bernard PL, Costa da Silva C, Guittard G, Nunes JA. Laletin V, et al. J Immunother Cancer. 2023 May;11(5):e005845. doi: 10.1136/jitc-2022-005845. J Immunother Cancer. 2023. PMID: 37217244 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous